SHOW DIRECTORY
The Shkreli Pill
Conversations selected for BidClub's technology and investment research archive. BidClub currently indexes 1 episodes.
BIDCLUB DESCRIPTION
Q3 Is Going to Shock the Market. I'm Extremely Bearish on Bitcoin & Space Stocks | Martin Shkreli
Shkreli expects NVIDIA’s Q3 guidance to shock the market if Singapore revenue he regards as China sales and circular financing disappear.His Lilly model reaches roughly $1,200 per share at an 8% discount rate, while shares near $1,500 require GLP revenue to triple and stay there, exposed to saturation and generics.Clinical strength may be priced in: CG Oncology’s 0.32 NMIBC recurrence-free-survival hazard ratio accompanied a retreat from about $100 to $80, while CoreWeave’s CDS comparison with Argentina raises a separate credit concern.
